SynCardia Systems, LLC ("SynCardia", or the "Company"), a Picard Medical, Inc. company, and the global leader in total artificial heart technology, is pleased to announce that the China National ...

Lilly Asia Ventures, Illumina Ventures, Bristol Myers Squibb, Osage University Partners, and Qatar Investment Authority. Finally, Swiss biotech LimmaTech Biologics cleared $37 million in a Series ...

Google appoints new COO Francis deSouza to lead Google Cloud AI, generative AI and cloud computing innovation strategy.

The Microfluidics market is projected to reach USD 32.67 Billion by 2029 from USD 22.43 Billion in 2024, growing at a CAGR of 7.8% during the forecast period.

He founded and invested for 10 years with 2050 Capital specialising in biotech and deep technology ventures ... has held senior executive positions at Illumina and the Bill & Melinda Gates ...

He founded and invested for 10 years with 2050 Capital specialising in biotech and deep technology ventures ... has held senior executive positions at Illumina and the Bill & Melinda Gates ...

And discover the most profitable, the fastest-growing and international contributors with our searchable tables.

The largest corporate owner of Bitcoin, MSTR will join the index on Dec. 23 alongside data firm Palantir and taser maker Axon Enterprise, replacing biotech stocks Moderna and Illumina and server ...

Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing ...

Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Illumina (ILMN) to $180 from $184 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech ...

Read Our Latest Stock Analysis on Illumina Illumina Trading Down 0.9 % Illumina stock opened at $143.12 on Wednesday. Illumina, Inc. has a 52-week low of $100.08 and a 52-week high of $156.66. The ...